Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
162M
-
Number of holders
-
226
-
Total 13F shares, excl. options
-
171M
-
Shares change
-
+653K
-
Total reported value, excl. options
-
$1.12B
-
Value change
-
-$4.92M
-
Put/Call ratio
-
0
-
Number of buys
-
112
-
Number of sells
-
-128
-
Price
-
$6.52
Significant Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q2 2024
302 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock as of Q2 2024.
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) has 226 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 171M shares
.
Largest 10 shareholders include BlackRock Inc. (22.9M shares), VANGUARD GROUP INC (21.6M shares), Sarissa Capital Management LP (16.4M shares), STATE STREET CORP (9.24M shares), Pacer Advisors, Inc. (8.91M shares), RENAISSANCE TECHNOLOGIES LLC (8.57M shares), ARMISTICE CAPITAL, LLC (7.8M shares), LSV ASSET MANAGEMENT (6.07M shares), MORGAN STANLEY (4.86M shares), and BRAIDWELL LP (4.44M shares).
This table shows the top 226 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.